1 completed, 1 terminated. 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Completed 1, Terminated 1 |
Follow Cheyne-Stokes Respiration: new trials by email Literature Review of Cheyne-Stokes Respiration trials Research Report on Cheyne-Stokes Respiration
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Chronic Evaluation of Respicardia Therapy remedē (TM) system - Sleep Disordered Breathing, Cheyne Stokes Respiration | Phase 2 | Completed | Respicardia, Inc. | 57 | 2010-05-01 | 2016-05-16 |
| Evaluation of the Effect of AVE0657 in Cheynes-Stokes Breathing Syndrome Patients AVE0657, placebo - Heart Failure, Sleep Apnea Syndromes | Phase 2 | Terminated | Sanofi | 8 | 2008-06-01 | 2009-05-01 |
Sleep Apnea Syndromes (2) · Heart Failure (1) · Sleep Apnea, Central (1)
Apnea (2) · Dyssomnias (2) · Nervous System Diseases (2) · Pathological Conditions, Signs and Symptoms (2) · Respiration Disorders (2) · Respiratory Tract Diseases (2) · Signs and Symptoms (2) · Signs and Symptoms, Respiratory (2) · Sleep Disorders, Intrinsic (2) · Sleep Wake Disorders (2) · Cardiovascular Diseases (1) · Heart Diseases (1)
Respicardia, Inc. (1) · Sanofi (1)
Germany (2) · France (1) · Italy (1) · Poland (1) · Spain (1) · United States (1)
Piotr Ponikowski, MD (1) · William T Abraham, MD (1)